Other Species / Isoforms
  BAP37 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K6-ub
__MAQNLkDLAGRLP
0 6
BAP37 (human) __MAQNLkDLAGRLP K6-ub
BAP37 iso2 (human) __MAQNLKDLAGRLP K6
BAP37 (mouse) __MAQNLkDLAGRLP K6-ub
BAP37 (rat) __MAQNLKDLAGRLP K6
K6-sc
__MAQNLkDLAGRLP
0 1
BAP37 (human) __MAQNLkDLAGRLP K6-sc
BAP37 iso2 (human) __MAQNLKDLAGRLP K6
BAP37 (mouse) __MAQNLkDLAGRLP K6-sc
BAP37 (rat) __MAQNLKDLAGRLP K6
K6-m1
__MAQNLkDLAGRLP
0 2
BAP37 (human) __MAQNLkDLAGRLP K6-m1
BAP37 iso2 (human) __MAQNLKDLAGRLP K6
BAP37 (mouse) __MAQNLKDLAGRLP K6
BAP37 (rat) __MAQNLKDLAGRLP K6
T21-p
AGPRGMGtALKLLLG
0 1
BAP37 (human) AGPRGMGtALKLLLG T21-p
BAP37 iso2 (human) AGPRGMGTALKLLLG T21
BAP37 (mouse) AGPRGMGTALKLLLG T21
BAP37 (rat) SGPRGMGTALKLLLG T21
Y34-p
LGAGAVAyGVREsVF
0 3
BAP37 (human) LGAGAVAyGVREsVF Y34-p
BAP37 iso2 (human) LGAGAVAYGVRESVF Y34
BAP37 (mouse) LGAGAVAYGVRESVF Y34
BAP37 (rat) LGAGAVAYGVRESVF Y34
S39-p
VAyGVREsVFTVEGG
Upstream
Downstream
2 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • autophagy, induced
Kinase, in vitro:
  • PKCA (human)
Phosphatases, in vitro:
  • PPP1CA (human)
Putative in vivo kinases:
  • AurA (human)
  • PKCA (human)
Treatment
  • 17-beta-estradiol
  • MLN8237
  • peptide inhibitor
  • siRNA
view more >
BAP37 (human) VAyGVREsVFTVEGG S39-p
BAP37 iso2 (human) VAYGVRESVFTVEGG S39
BAP37 (mouse) VAYGVRESVFTVEGG S39
BAP37 (rat) VAYGVRESVFTVEGG S39
Y77-p
FRIPWFQyPIIyDIR
0 48
BAP37 (human) FRIPWFQyPIIyDIR Y77-p
BAP37 iso2 (human) FRIPWFQYPIIYDIR Y77
BAP37 (mouse) FRIPWFQyPIIYDIR Y77-p
BAP37 (rat) FRIPWFQyPIIYDIR Y77-p
Y81-p
WFQyPIIyDIRARPR
0 8
BAP37 (human) WFQyPIIyDIRARPR Y81-p
BAP37 iso2 (human) WFQYPIIYDIRARPR Y81
BAP37 (mouse) WFQyPIIYDIRARPR Y81
BAP37 (rat) WFQyPIIYDIRARPR Y81
K89-ub
DIRARPRkIssPTGS
0 3
BAP37 (human) DIRARPRkIssPTGS K89-ub
BAP37 iso2 (human) DIRARPRKISSPTGS K89
BAP37 (mouse) DIRARPRKIssPTGS K89
BAP37 (rat) DIRARPRKISSPTGS K89
K89-ac
DIRARPRkIssPTGS
0 13
BAP37 (human) DIRARPRkIssPTGS K89-ac
BAP37 iso2 (human) DIRARPRKISSPTGS K89
BAP37 (mouse) DIRARPRKIssPTGS K89
BAP37 (rat) DIRARPRKISSPTGS K89
S91-p
RARPRkIssPTGSkD
Upstream
Downstream
2 10
Effects on Biological Processes:
  • apoptosis, inhibited
  • transcription, induced
Kinase, in vitro:
  • Akt1 (human)
  • Akt2 (human)
  • CAMK4 (human)
view more >
Putative in vivo kinases:
  • Akt1 (human)
  • CAMK4 (human)
Treatment
  • retinoic_acid
BAP37 (human) RARPRkIssPTGSkD S91-p
BAP37 iso2 (human) RARPRKISSPTGSKD S91
BAP37 (mouse) RARPRKIssPTGSkD S91-p
BAP37 (rat) RARPRKISSPTGSkD S91
S92-p
ARPRkIssPTGSkDL
0 4
BAP37 (human) ARPRkIssPTGSkDL S92-p
BAP37 iso2 (human) ARPRKISSPTGSKDL S92
BAP37 (mouse) ARPRKIssPTGSkDL S92-p
BAP37 (rat) ARPRKISSPTGSkDL S92
K97-ub
IssPTGSkDLQMVNI
0 2
BAP37 (human) IssPTGSkDLQMVNI K97-ub
BAP37 iso2 (human) ISSPTGSKDLQMVNI K97
BAP37 (mouse) IssPTGSKDLQMVNI K97
BAP37 (rat) ISSPTGSKDLQMVNI K97
K97
IssPTGSKDLQMVNI
0 1
BAP37 (human) IssPTGSKDLQMVNI K97
BAP37 iso2 (human) ISSPTGSKDLQMVNI K97
BAP37 (mouse) IssPTGSkDLQMVNI K97-sc
BAP37 (rat) ISSPTGSKDLQMVNI K97
K97-ac
IssPTGSkDLQMVNI
0 2
BAP37 (human) IssPTGSkDLQMVNI K97-ac
BAP37 iso2 (human) ISSPTGSKDLQMVNI K97
BAP37 (mouse) IssPTGSkDLQMVNI K97-ac
BAP37 (rat) ISSPTGSkDLQMVNI K97-ac
S105-p
DLQMVNIsLRVLSRP
0 1
BAP37 (human) DLQMVNIsLRVLSRP S105-p
BAP37 iso2 (human) DLQMVNISLRVLSRP S105
BAP37 (mouse) DLQMVNISLRVLSRP S105
BAP37 (rat) DLQMVNISLRVLSRP S105
S119-p
PNAQELPsMyQrLGL
0 2
BAP37 (human) PNAQELPsMyQrLGL S119-p
BAP37 iso2 (human) PNAQELPSMYQRLGL S119
BAP37 (mouse) PNAQELPSMyQRLGL S119
BAP37 (rat) PNAQELPSMyQRLGL S119
Y121-p
AQELPsMyQrLGLDy
Downstream
1 141
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • autophagy, altered
BAP37 (human) AQELPsMyQrLGLDy Y121-p
BAP37 iso2 (human) AQELPSMYQRLGLDY Y121
BAP37 (mouse) AQELPSMyQRLGLDY Y121-p
BAP37 (rat) AQELPSMyQRLGLDY Y121-p
R123-m1
ELPsMyQrLGLDyEE
0 1
BAP37 (human) ELPsMyQrLGLDyEE R123-m1
BAP37 iso2 (human) ELPSMYQRLGLDYEE R123
BAP37 (mouse) ELPSMyQRLGLDYEE R123
BAP37 (rat) ELPSMyQRLGLDYEE R123
Y128-p
yQrLGLDyEERVLPs
0 17
BAP37 (human) yQrLGLDyEERVLPs Y128-p
BAP37 iso2 (human) YQRLGLDYEERVLPS Y128
BAP37 (mouse) yQRLGLDYEERVLPS Y128
BAP37 (rat) yQRLGLDYEERVLPS Y128
S135-p
yEERVLPsIVNEVLk
0 2
BAP37 (human) yEERVLPsIVNEVLk S135-p
BAP37 iso2 (human) YEERVLPSIVNEVLK S135
BAP37 (mouse) YEERVLPSIVNEVLK S135
BAP37 (rat) YEERVLPSIVNEVLk S135
K142
sIVNEVLKSVVAkFN
0 1
BAP37 (human) sIVNEVLKSVVAkFN K142
BAP37 iso2 (human) SIVNEVLKSVVAKFN K142
BAP37 (mouse) SIVNEVLKSVVAkFN K142
BAP37 (rat) SIVNEVLkSVVAkFN K142-ac
K142-ub
sIVNEVLkSVVAkFN
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
  • ubiquitination
Effects on Biological Processes:
  • autophagy, induced
BAP37 (human) sIVNEVLkSVVAkFN K142-ub
BAP37 iso2 (human) SIVNEVLKSVVAKFN K142
BAP37 (mouse) SIVNEVLKSVVAkFN K142
BAP37 (rat) SIVNEVLKSVVAkFN K142
K147-ub
VLkSVVAkFNAsQLI
0 2
BAP37 (human) VLkSVVAkFNAsQLI K147-ub
BAP37 iso2 (human) VLKSVVAKFNASQLI K147
BAP37 (mouse) VLKSVVAKFNAsQLI K147
BAP37 (rat) VLkSVVAKFNAsQLI K147
K147-ac
VLkSVVAkFNAsQLI
0 5
BAP37 (human) VLkSVVAkFNAsQLI K147-ac
BAP37 iso2 (human) VLKSVVAKFNASQLI K147
BAP37 (mouse) VLKSVVAkFNAsQLI K147-ac
BAP37 (rat) VLkSVVAkFNAsQLI K147-ac
S151-p
VVAkFNAsQLItQRA
0 22
BAP37 (human) VVAkFNAsQLItQRA S151-p
BAP37 iso2 (human) VVAKFNASQLITQRA S151
BAP37 (mouse) VVAkFNAsQLItQRA S151-p
BAP37 (rat) VVAkFNAsQLItQRA S151-p
T155-p
FNAsQLItQRAQVsL
0 9
BAP37 (human) FNAsQLItQRAQVsL T155-p
BAP37 iso2 (human) FNASQLITQRAQVSL T155
BAP37 (mouse) FNAsQLItQRAQVsL T155-p
BAP37 (rat) FNAsQLItQRAQVSL T155-p
S161-p
ItQRAQVsLLIRREL
0 4
BAP37 (human) ItQRAQVsLLIRREL S161-p
BAP37 iso2 (human) ITQRAQVSLLIRREL S161
BAP37 (mouse) ItQRAQVsLLIRREL S161-p
BAP37 (rat) ItQRAQVSLLIRREL S161
S176-p
TERAKDFsLILDDVA
Upstream
1 1
Kinase, in vitro:
  • Akt1 (human)
  • Akt2 (human)
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • retinoic_acid
BAP37 (human) TERAKDFsLILDDVA S176-p
BAP37 iso2 (human) TERAKDFSLILDDVA S176
BAP37 (mouse) TERAKDFSLILDDVA S176
BAP37 (rat) TERAKDFSLILDDVA S176
K200-ub
YTAAVEAkQVAQQEA
Downstream
1 6
Effects on Modified Protein
  • molecular association, regulation
  • ubiquitination
Effects on Biological Processes:
  • autophagy, induced
BAP37 (human) YTAAVEAkQVAQQEA K200-ub
BAP37 iso2 (human) YTAAVEAKQVALSKN K200
BAP37 (mouse) YTAAVEAKQVAQQEA K200
BAP37 (rat) YTAAVEAKQVAQQEA K200
K200
YTAAVEAKQVAQQEA
0 3
BAP37 (human) YTAAVEAKQVAQQEA K200
BAP37 iso2 (human) YTAAVEAKQVALSKN K200
BAP37 (mouse) YTAAVEAkQVAQQEA K200-ac
BAP37 (rat) YTAAVEAkQVAQQEA K200-ac
K216-ac
RAQFLVEkAKQEQRQ
0 5
BAP37 (human) RAQFLVEkAKQEQRQ K216-ac
BAP37 iso2 (human) gap -
BAP37 (mouse) RAQFLVEkAKQEQRQ K216-ac
BAP37 (rat) RAQFLVEkAKQEQRQ K216-ac
K216-ub
RAQFLVEkAKQEQRQ
0 2
BAP37 (human) RAQFLVEkAKQEQRQ K216-ub
BAP37 iso2 (human) gap -
BAP37 (mouse) RAQFLVEKAKQEQRQ K216
BAP37 (rat) RAQFLVEKAKQEQRQ K216
K224-ub
AKQEQRQkIVQAEGE
0 3
BAP37 (human) AKQEQRQkIVQAEGE K224-ub
BAP37 iso2 (human) gap -
BAP37 (mouse) AKQEQRQkIVQAEGE K224-ub
BAP37 (rat) AKQEQRQKIVQAEGE K224
K236-ub
EGEAEAAkMLGEALs
0 4
BAP37 (human) EGEAEAAkMLGEALs K236-ub
BAP37 iso2 (human) gap -
BAP37 (mouse) EGEAEAAKMLGEALS K236
BAP37 (rat) EGEAEAAKMLGEALS K236
K236
EGEAEAAKMLGEALs
0 2
BAP37 (human) EGEAEAAKMLGEALs K236
BAP37 iso2 (human) gap -
BAP37 (mouse) EGEAEAAkMLGEALS K236-ac
BAP37 (rat) EGEAEAAkMLGEALS K236-ac
S243-p
kMLGEALskNPGyIk
1 1
BAP37 (human) kMLGEALskNPGyIk S243-p
BAP37 iso2 (human) EAKQVALSKNPGYIK S205
BAP37 (mouse) kMLGEALSKNPGyIK S243
BAP37 (rat) kMLGEALSKNPGyIk S243
K244-ub
MLGEALskNPGyIkL
Upstream
0 5
Treatment
  • MG132
BAP37 (human) MLGEALskNPGyIkL K244-ub
BAP37 iso2 (human) AKQVALSKNPGYIKL K206
BAP37 (mouse) MLGEALSKNPGyIKL K244
BAP37 (rat) MLGEALSKNPGyIkL K244
Y248-p
ALskNPGyIkLRKIR
Upstream
1 254
Regulatory protein:
  • CSFR (human)
Treatment
  • imatinib
BAP37 (human) ALskNPGyIkLRKIR Y248-p
BAP37 iso2 (human) ALSKNPGYIKLRKIR Y210
BAP37 (mouse) ALSKNPGyIKLRKIR Y248-p
BAP37 (rat) ALSKNPGyIkLRKIR Y248-p
K250-ac
skNPGyIkLRKIRAA
Upstream
0 3
Treatment
  • vorinostat
BAP37 (human) skNPGyIkLRKIRAA K250-ac
BAP37 iso2 (human) SKNPGYIKLRKIRAA K212
BAP37 (mouse) SKNPGyIKLRKIRAA K250
BAP37 (rat) SKNPGyIkLRKIRAA K250-ac
K250-ub
skNPGyIkLRKIRAA
0 3
BAP37 (human) skNPGyIkLRKIRAA K250-ub
BAP37 iso2 (human) SKNPGYIKLRKIRAA K212
BAP37 (mouse) SKNPGyIKLRKIRAA K250
BAP37 (rat) SKNPGyIKLRKIRAA K250
K262-ub
RAAQNISktIAtSQN
0 5
BAP37 (human) RAAQNISktIAtSQN K262-ub
BAP37 iso2 (human) RAAQNISKTIATSQN K224
BAP37 (mouse) RAAQNISkTIATsQN K262-ub
BAP37 (rat) RAAQNISKTIATSQN K262
T263-p
AAQNISktIAtSQNR
0 1
BAP37 (human) AAQNISktIAtSQNR T263-p
BAP37 iso2 (human) AAQNISKTIATSQNR T225
BAP37 (mouse) AAQNISkTIATsQNR T263
BAP37 (rat) AAQNISKTIATSQNR T263
T266-p
NISktIAtSQNRIYL
0 1
BAP37 (human) NISktIAtSQNRIYL T266-p
BAP37 iso2 (human) NISKTIATSQNRIYL T228
BAP37 (mouse) NISkTIATsQNRIYL T266
BAP37 (rat) NISKTIATSQNRIYL T266
S267
ISktIAtSQNRIYLT
0 1
BAP37 (human) ISktIAtSQNRIYLT S267
BAP37 iso2 (human) ISKTIATSQNRIYLT S229
BAP37 (mouse) ISkTIATsQNRIYLT S267-p
BAP37 (rat) ISKTIATSQNRIYLT S267
S286-p
VLNLQDEsFTrGSDs
0 1
BAP37 (human) VLNLQDEsFTrGSDs S286-p
BAP37 iso2 (human) VLNLQDESFTRGSDS S248
BAP37 (mouse) VLNLQDESFTRGSDs S286
BAP37 (rat) VLNLQDESFTRGSDs S286
R289-m1
LQDEsFTrGSDsLIk
0 1
BAP37 (human) LQDEsFTrGSDsLIk R289-m1
BAP37 iso2 (human) LQDESFTRGSDSLIK R251
BAP37 (mouse) LQDESFTRGSDsLIK R289
BAP37 (rat) LQDESFTRGSDsLIK R289
S293-p
sFTrGSDsLIkGKK_
0 13
BAP37 (human) sFTrGSDsLIkGKK_ S293-p
BAP37 iso2 (human) SFTRGSDSLIKGKK_ S255
BAP37 (mouse) SFTRGSDsLIKGKK_ S293-p
BAP37 (rat) SFTRGSDsLIKGKK_ S293-p
K296-ub
rGSDsLIkGKK____
0 2
BAP37 (human) rGSDsLIkGKK____ K296-ub
BAP37 iso2 (human) RGSDSLIKGKK____ K258
BAP37 (mouse) RGSDsLIKGKK____ K296
BAP37 (rat) RGSDsLIKGKK____ K296